238 related articles for article (PubMed ID: 2833127)
1. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.
Martinez S; Looker DL; Marr JJ
Am J Trop Med Hyg; 1988 Mar; 38(2):304-7. PubMed ID: 2833127
[TBL] [Abstract][Full Text] [Related]
2. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
Martinez S; Looker DL; Berens RL; Marr JJ
Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
[TBL] [Abstract][Full Text] [Related]
3. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.
Looker DL; Martinez S; Horton JM; Marr JJ
J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012
[TBL] [Abstract][Full Text] [Related]
4. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
Beach DH; Goad LJ; Holz GG
Mol Biochem Parasitol; 1988 Nov; 31(2):149-62. PubMed ID: 2847043
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
6. Leishmania spp.: agar plating as an alternative to limiting dilution and impression smears for the enumeration of viable parasites in tissue.
Hill JO; Fahey JR
Exp Parasitol; 1987 Feb; 63(1):108-11. PubMed ID: 3803532
[No Abstract] [Full Text] [Related]
7. [Evolution of the interrelation of the linking members in the Leishmania parasite system].
Saf'ianova VM
Med Parazitol (Mosk); 1986; (2):43-8. PubMed ID: 3086683
[No Abstract] [Full Text] [Related]
8. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
9. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana.
Zakai HA; Chance ML; Bates PA
Parasitology; 1998 Apr; 116 ( Pt 4)():305-9. PubMed ID: 9585932
[TBL] [Abstract][Full Text] [Related]
11. [Active antihelminitic alkaloids: active in vitro against Leishmanic Tropica the protozoa involved in leishmaniasis].
Fournet A; Muñoz V; Manjon AM; Angelo A; Hocquemiller R; Cortes D; Cave A; Bruneton J
J Ethnopharmacol; 1988 Dec; 24(2-3):327-35. PubMed ID: 3253497
[TBL] [Abstract][Full Text] [Related]
12. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals.
Mottram JC; Coombs GH
Exp Parasitol; 1985 Apr; 59(2):151-60. PubMed ID: 2982638
[TBL] [Abstract][Full Text] [Related]
13. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
Ephros M; Waldman E; Zilberstein D
Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
[TBL] [Abstract][Full Text] [Related]
14. Requirements of defined cultivation conditions for standard growth of Leishmania promastigotes in vitro.
Lemesre JL; Darcy F; Kweider M; Capron A; Santoro F
Acta Trop; 1988 Jun; 45(2):99-108. PubMed ID: 2901211
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components.
Grogl M; Martin RK; Oduola AM; Milhous WK; Kyle DE
Am J Trop Med Hyg; 1991 Jul; 45(1):98-111. PubMed ID: 1678253
[TBL] [Abstract][Full Text] [Related]
16. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.
Neal RA; van Bueren J; Hooper G
Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778
[TBL] [Abstract][Full Text] [Related]
17. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
Romero AH; Rodríguez N; Oviedo H; Lopez SE
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
[TBL] [Abstract][Full Text] [Related]
18. Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
Shimony O; Jaffe CL
J Microbiol Methods; 2008 Oct; 75(2):196-200. PubMed ID: 18573286
[TBL] [Abstract][Full Text] [Related]
19. In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents.
Berman JD; Gallalee JV
J Parasitol; 1987 Jun; 73(3):671-3. PubMed ID: 3037057
[No Abstract] [Full Text] [Related]
20. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
